Publication Name	World Journal of Methodology
Manuscript ID	95881
Country	India

Category	Ophthalmology
Manuscript Type	Review
Article Title	Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities
Manuscript Source	Invited Manuscript
All Author List	Arvind Kumar Morya, Prasanna Venkatesh Ramesh, Prateek Nishant, Kirandeep Kaur, Bharat Gurnani, Aarti Heda and Sarika Salodia
Funding Agency and Grant Number
Corresponding Author	Arvind Kumar Morya, Doctor, MS, Doctor, Doctor, Neurosurgeon, Professor, Researcher, Senior Lecturer, Senior Researcher, Surgeon, Head of the Department, Department of Ophthalmology, All India Institute of Medical Sciences, Bibi Nagar, Hyderabad 508126, Telangana, India. bulbul.morya@gmail.com
Key Words	Diabetes; Diabetic retinopathy; Diabetic macular edema; Intravitreal injection; Laser photocoagulation
Core Tip	Diabetic retinopathy (DR) is a complication of diabetes mellitus that is a potential threat to the vision of patients. In patients with diabetes, regular ocular examination is essential to diagnose the disease at an early stage, and timely screening and diagnosis play an important part in a better prognosis. Non-proliferative diabetic retinopathy (NPDR) requires regular follow-up and treatment as and when needed. In proliferative diabetic retinopathy (PDR), the effectiveness of laser photocoagulation is time-bound, the earlier the better. Advanced DR stages require a more intensive approach such as vitreoretinal surgery, and PDR is associated with limited visual prognosis. Despite the multiple therapeutic approaches that are currently available for DR patients, such as intravitreal injections and sutureless pars plana vitrectomy, an interdisciplinary approach remains a mandate to treat these patients. Diabetic patients require good glycemic control as well as blood pressure control to reduce the risk of associated ophthalmic complications.
Citation	<p>Morya AK, Ramesh PV, Nishant P, Kaur K, Gurnani B, Heda A, Salodia S. Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities. <i>World J Methodol</i> 2024; 14(4): 95881</p>

Received	2024-04-21 08:36
Peer-Review Started	2024-04-21 08:36
To Make the First Decision
Return for Revision	2024-05-14 09:59
Revised	2024-05-28 11:33
Second Decision	2024-07-08 02:46
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-07-10 07:48
Articles in Press	2024-07-10 07:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-07-17 17:21
Typeset the Manuscript	2024-07-22 08:32

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com